Zhu Qing, Yu Qin, Liu Mengyao, Wei Yongqing
Department of Obstetrics, Jinan Central Hospital affiliated to Shandong First Medical University, No.105, Jiefang Road, Jinan 250013, China.
Department of Obstetrics, Jinan Central Hospital affiliated to Shandong First Medical University, No.105, Jiefang Road, Jinan 250013, China.
Pregnancy Hypertens. 2024 Dec;38:101174. doi: 10.1016/j.preghy.2024.101174. Epub 2024 Nov 29.
Gestational hypertension and related disorders, such as preeclampsia, pose significant risks to maternal and foetal health. Calcium supplementation has been proposed as a preventive measure, but its effectiveness remains debated. This review assess the impact of calcium supplementation in prevention of gestational hypertension.
A comprehensive literature search was conducted across multiple databases, including Scopus, EMBASE, PubMed, Web of Science, CINAHL, Cochrane CENTRAL, from inception to July 2024. Eligibility criteria included studies involving pregnant women at risk of gestational hypertension, comparing calcium supplementation to control group, and reporting on outcomes such as preeclampsia, pregnancy-induced hypertension, HELLP syndrome, preterm birth, and maternal mortality. Data were analysed using a random-effects inverse-variance model to calculate pooled risk ratios (RRs) and assess heterogeneity using Cochran's Q and I2 statistics. Publication bias was evaluated using funnel plots and Egger's test.
22 studies with 39,270 individuals were included. Most studies had higher risk of bias. Calcium supplementation significantly reduced the risk of preeclampsia (pooled RR = 0.606, 95 %CI: 0.483-0.761, p < 0.001) and pregnancy-induced hypertension (pooled RR = 0.870, 95 %CI: 0.759-0.996, p = 0.044). However, it showed no significant effect on HELLP syndrome, preterm birth, or mortality. Heterogeneity was moderate to substantial across outcomes, and publication bias was detected for preterm birth and pregnancy-induced hypertension.
Calcium supplementation during pregnancy significantly reduces the risk of preeclampsia and pregnancy-induced hypertension, highlighting its value as a cost-effective intervention for improving maternal health. These findings support integrating calcium supplementation into prenatal care strategies, particularly for populations with low dietary calcium intake.
妊娠期高血压及相关疾病,如先兆子痫,对孕产妇和胎儿健康构成重大风险。补充钙已被提议作为一种预防措施,但其有效性仍存在争议。本综述评估补充钙在预防妊娠期高血压中的作用。
从数据库建立至2024年7月,在多个数据库(包括Scopus、EMBASE、PubMed、Web of Science、CINAHL、Cochrane CENTRAL)中进行了全面的文献检索。纳入标准包括涉及有妊娠期高血压风险的孕妇的研究,将补充钙组与对照组进行比较,并报告先兆子痫、妊娠高血压、HELLP综合征、早产和孕产妇死亡率等结局。采用随机效应逆方差模型分析数据,计算合并风险比(RRs),并使用Cochran's Q和I²统计量评估异质性。使用漏斗图和Egger检验评估发表偏倚。
纳入了22项研究,共39270人。大多数研究存在较高的偏倚风险。补充钙显著降低了先兆子痫的风险(合并RR = 0.606,95%CI:0.483 - 0.761,p < 0.001)和妊娠高血压的风险(合并RR = 0.870,95%CI:0.759 - 0.996,p = 0.044)。然而,它对HELLP综合征、早产或死亡率没有显著影响。各结局的异质性为中度至高度,并且在早产和妊娠高血压方面检测到发表偏倚。
孕期补充钙显著降低了先兆子痫和妊娠高血压的风险,凸显了其作为改善孕产妇健康的经济有效干预措施的价值。这些发现支持将补充钙纳入产前保健策略,特别是对于饮食钙摄入量低的人群。